Telmisartan CAS 144701-48-4
Identification
Properties
Safety Data
Specifications & Other Information
Links
Identification
CAS Number
144701-48-4
Name
Telmisartan
Synonyms
[1,1′-Biphenyl]-2-carboxylic acid, 4′-[(1,4′-dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]- [ACD/Index Name]
144701-48-4 [RN]
4′-[(1,7′-Dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]-2-biphenylcarbonsäure [German] [ACD/IUPAC Name]
4′-[(1,7′-Dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]-2-biphenylcarboxylic acid [ACD/IUPAC Name]
4′-[(1,7′-Dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]biphenyl-2-carbonsäure [German]
4′-[(1,7′-dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]biphenyl-2-carboxylic acid
7144
Acide 4′-[(1,7′-diméthyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)méthyl]-2-biphénylcarboxylique [French] [ACD/IUPAC Name]
acide 4′-[(1,7′-diméthyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)méthyl]biphényl-2-carboxylique [French]
Kinzalmono [Trade name]
Micardis [Trade name]
Pritor [Trade name]
telmisartan [French] [INN]
Telmisartan [INN] [JAN] [USAN] [Wiki]
telmisartán [Spanish] [INN]
telmisartanum [Latin] [INN]
U5SYW473RQ
телмисартан [Russian] [INN]
تيلميسارتان [Arabic] [INN]
替米沙坦 [Chinese] [INN]
(1,1′-Biphenyl)-2-carboxylic acid, 4′-((1,4′-dimethyl-2′-propyl(2,6′-bi-1H-benzimidazol)-1′-yl)methyl)-
[1,1′-biphenyl]-2-carboxylic acid, 4′[(1,4′-dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]
[144701-48-4]
1189889-44-8 [RN]
2-(4-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid
2-[4-[[4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]phenyl]benzoic acid
2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid
2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-benzimidazol-1-yl]methyl]phenyl]benzoic acid
2-[4-[[4-methyl-6-(1-methylbenzoimidazol-2-yl)-2-propyl-benzoimidazol-1-yl]methyl]phenyl]benzoic acid
4′-((1,4′-dimethyl-2′-propyl(2,6′-bi-1H-benzimidazol)-1′-yl)methyl)-(1,1′-biphenyl)-2-carboxylic acid
4-((1,7-dimethyl-2-propyl-1h,3h-[2,5-bibenzo[d]imidazol]-3-yl)methyl)-[1,1-biphenyl]-2-carboxylic acid
4′-((1,7′-dimethyl-2′-propyl-1H,3’H-[2,5′-bibenzo[d]imidazol]-3′-yl)methyl)-[1,1′-biphenyl]-2-carboxylic acid
4′-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid
4-(1,4-Dimethyl-2-propyl-2,6-bi-1H-benzimidazol-1-yl)methyl-1,1-biphenyl-2-carboxylicacid
4′-(1,7′-Dimethyl-2′-propyl-1H-[2,5′]bibenzoimidazolyl-3′-ylmethyl)-biphenyl-2-carboxylic acid
4′-?[(1,?4′-?DIMETHYL-?2′-?PROPYL[2,?6′-?BI-?1H-?BENZIMIDAZOL]-?1′-?YL)METHYL]-?[1,?1′-?BIPHENYL]-?2-?CARBOXYLIC ACID
4′-[(1,4′-dimethyl-2’propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]-[1,1′-biphenyl]-2-carboxylic acid
4′-[(1,4′-dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]-[1,1′-biphenyl]-2-carboxylic acid
4′[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid
4′-[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid
4′-[(1,7′-dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid
4-[(1,7-dimethyl-2-propyl-1h,3h-2,5-bibenzimidazol-3-yl)methyl]biphenyl-2-carboxylic acid
4′[(1,7′-dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]biphenyl-2-carboxylic acid
4′-[[1,4′-Dimethyl-2′-propyl(2,6′-bi-1H-benzimidazol)-1′-yl]-methyl]-1,1′-biphenyl-2-carboxylic acid 1,1-dimethylethyl ester
4′-[[4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]-2-biphenylcarboxylic acid
4′[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid
6624054 [Beilstein]
BAY-68-9291
BIBR 277 SE
BIBR 277;Micardis;Pritor;Telday
BIBR 277SE
BIBR277
BIBR-277SE
BIBR-277-SE
BR-72892
BSPBio_002738
C33H30N4O2
Carbon monoxide releasing molecule 3 |
DV2037500
Kinzal
MFCD00918125 [MDL number]
Micardis (TN)
MICARDIS HCT
Micardis®
MLS000759432
NCGC00095150-01
NCGC00095150-02
Pharmakon1600-01505261
Pritor®
SMR000466326
SPECTRUM1505261
Spectrum5_001053
Targit
Targit;Temax;BIBR277;Micardis
Telday
Teleact D
Telma
Telmisartan (JAN/USAN/INN)
Telmisartan (Micardis)
TELMISARTAN-D3
Telmisattan
Temax
TL8000991
TLS
UNII:U5SYW473RQ
UNII-U5SYW473RQ
Molecular Structure

Structure of Telmisartan CAS 144701-48-4
SMILES
CCCc1nc2c(cc(cc2n1Cc3ccc(cc3)c4ccccc4C(=O)O)c5nc6ccccc6n5C)C
StdInChI
InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)
StdInChIKey
RMMXLENWKUUMAY-UHFFFAOYSA-N
Molecular Formula
C33H30N4O2
Molecular Weight
514.62
MDL Number
MFCD00918125
Safety Data
Personal Protective Equipment
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
RIDADR
NONH for all modes of transport
WGK Germany
2
Specifications and Other Information of Our Telmisartan CAS 144701-48-4
Standard
EP, USP
GMP
LCFDA
Basic Patent Situation
US expiry date | 20140107 |
EU expiry date | 20120131 (20170130) |
JP expiry date | 20170125 |
Package
According to customer requirements to packaging
Storage
Under the room temperature and away from light
Application
Used as the Angiotensin II Receptor Antagonist.
Links
Watson International Ltd
This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/telmisartan-cas-144701-48-4/